摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-甲氧苯基)马来酸 | 36847-94-6

中文名称
N-(2-甲氧苯基)马来酸
中文别名
(E)-4-[(2-甲氧苯基)氨基]-4-氧代-丁-2-烯酸;(E)-4-氧代-4-[(2-甲氧苯基)氨基]丁-2-烯酸;(2E)-4-[(2-甲氧苯基)氨基]-4-氧代丁-2-烯酸;4-[(2-甲氧苯基)氨基]-4-氧代-丁-2-烯酸
英文名称
4-(2-methoxyanilino)-4-oxo-2-butenoic acid n-α-fmoc-α-(tert-butyl ester)
英文别名
(Z)-4-(2-methoxyanilino)-4-oxobut-2-enoic acid;4-(2-methoxyanilino)-4-oxobut-2-enoic acid
N-(2-甲氧苯基)马来酸化学式
CAS
36847-94-6
化学式
C11H11NO4
mdl
MFCD00136426
分子量
221.213
InChiKey
HGLMERMZXFKZOL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    143-145°C
  • 沸点:
    468.9±45.0 °C(Predicted)
  • 密度:
    1.318±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险类别码:
    R36/37/38
  • 海关编码:
    2924299090
  • 安全说明:
    S26,S36

SDS

SDS:b8cea92deea6eab2204d41d694fcdcc2
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 4-(2-METHOXYANILINO)-4-OXO-2-BUTENOIC
ACID
CAS-No. : 36847-94-6
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 4)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Harmful if swallowed.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R22 Harmful if swallowed.
S-phrase(s) none
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C11H11NO4
Molecular Weight : 221,22 g/mol
Component Concentration
4-(2-METHOXYANILINO)-4-OXO-2-BUTENOIC ACID
CAS-No. 36847-94-6 -

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 1,908
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion Harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    氧化石墨烯在水介质中作为Diels-Alder反应的碳催化剂
    摘要:
    Diels–Alder(DA)反应是[4 + 2]环加成反应,在合成有机化学中非常重要,经常用于合成包含六元环的天然产物。在本文中,我们报告了在室温下使用二维氧化石墨烯(GO)作为非均相碳催化剂在9-羟甲基蒽和N-取代的马来酰亚胺之间进行DA反应的有效方案。高收率,广泛的底物范围,低温,出色的官能团耐受性,原子经济性以及水作为绿色溶剂是该协议的重要功能。该多相GO催化剂可以容易地回收并多次使用,而催化活性没有任何明显的损失。
    DOI:
    10.1002/asia.201701072
  • 作为产物:
    描述:
    马来酸酐邻甲氧基苯胺乙醚 为溶剂, 反应 2.0h, 生成 N-(2-甲氧苯基)马来酸
    参考文献:
    名称:
    氧化石墨烯在水介质中作为Diels-Alder反应的碳催化剂
    摘要:
    Diels–Alder(DA)反应是[4 + 2]环加成反应,在合成有机化学中非常重要,经常用于合成包含六元环的天然产物。在本文中,我们报告了在室温下使用二维氧化石墨烯(GO)作为非均相碳催化剂在9-羟甲基蒽和N-取代的马来酰亚胺之间进行DA反应的有效方案。高收率,广泛的底物范围,低温,出色的官能团耐受性,原子经济性以及水作为绿色溶剂是该协议的重要功能。该多相GO催化剂可以容易地回收并多次使用,而催化活性没有任何明显的损失。
    DOI:
    10.1002/asia.201701072
点击查看最新优质反应信息

文献信息

  • Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
    作者:Baihui Li、Yangli Shen、Hu Wu、Xiaobo Wu、Lvjiang Yuan、Qinggang Ji
    DOI:10.1016/j.ejmech.2020.112278
    日期:2020.6
    A series of 3,4-dihydro-2(1H)-quinolinone derivatives contained butenediamide fragment were designed and synthesized. Their inhibition potency against chitin synthase and antimicrobial activities were screened in vitro. The enzymatic assays showed that all the synthesized compounds had inhibition potency against chitin synthase at concentration of 300 μg/mL. Compound 2d displayed excellent potency
    设计合成了一系列含有丁烯二酰胺片段的3,4-二氢-2(1H)-喹啉酮衍生物。在体外筛选了它们对几丁质合酶的抑制能力和抗菌活性。酶促测定表明,所有合成的化合物在300μg/ mL的浓度下均具有针对甲壳质合酶的抑制能力。化合物2d表现出优异的效能,抑制百分数(IP)值为82.3%,而对照多恶菌素B的IP值为87.5%。IP值高于70%的化合物2b,2e和2s显示出对几丁质合酶的良好抑制能力。此外,2b的IC50值可与多恶英B(0.09 mM)相媲美。化合物2b的Ki为0.12 mM,Lineweaver-Burk图的结果表明2b是与甲壳质合酶结合的非竞争性抑制剂。抗真菌实验表明,这些化合物对真菌菌株,特别是白色念珠菌具有优异的抗真菌活性。化合物2b,2d,2e和2l对白念珠菌的抗真菌活性与氟康唑相当,并且优于多恶灵B。同时,其他化合物对白念珠菌的抗真菌活性也更好(MIC 2μg/ mL )比化合物2n(MIC
  • Design, synthesis, and biological evaluation of novel spiro[pyrrolidine-2,3′-quinolin]-2′-one derivatives as potential chitin synthase inhibitors and antifungal agents
    作者:Hu Wu、Chuanbiao Du、Yajie Xu、Lige Liu、Xin Zhou、Qinggang Ji
    DOI:10.1016/j.ejmech.2022.114208
    日期:2022.4
    fumigatus and A. flavus as high as fluconazole had, respectively. The sorbitol protection assay and evaluation of antifungal activity against micafungin-resistant strain further verified that these compounds possessed antifungal activity through inhibiting the synthesis of chitin of cell wall. The evaluation of antifungal activity against others drug-resistant fungi variants showed these designed compounds
    设计合成了一系列新型螺喹啉酮衍生物,并通过光谱方法对其结构进行了确证。酶学实验表明,合成的17种化合物均对几丁质合酶具有抑制作用,其中5种化合物具有与多毒素B相当的抑制作用。酶学动力学参数表明,这些化合物是几丁质的非竞争性抑制剂。合酶。抗菌实验表明,合成的化合物在体外具有选择性和广谱的抗真菌活性,其中两种化合物对白色念珠菌的抗真菌活性强于氟康唑,另外5种化合物对白念珠菌的抗真菌活性强于氟康唑。白色念珠菌等同于氟康唑。此外,有四种或五种化合物分别具有与氟康唑一样高的对新型念珠菌、烟曲霉和黄曲霉的抗真菌活性。山梨醇保护试验和对米卡芬净耐药菌株的抗真菌活性评价进一步证实了这些化合物通过抑制细胞壁几丁质的合成而具有抗真菌活性。对其他耐药真菌变体的抗真菌活性评估表明,这些设计的化合物对这些测试变体具有显着的抗真菌活性。联合使用实验表明,合成的化合物与目前临床上使用的药物具有协同作用或相加作用。这些结
  • Spiro[benzoxazine-piperidin]-one derivatives as chitin synthase inhibitors and antifungal agents: Design, synthesis and biological evaluation
    作者:Yajie Xu、Yangli Shen、Chuanbiao Du、Lige Liu、Hu Wu、Qingggang Ji
    DOI:10.1016/j.ejmech.2022.114723
    日期:2022.12
    Four series of spiro[benzoxazine-piperidin]-one derivatives were designed and synthesized. Their inhibition percentages against chitin synthase and antifungal activities were evaluated. Based on the preliminary biological assays, the series of derivatives containing α, β-unsaturated carbonyl fragment which had moderate to excellent CHS inhibitory activity and antifungal activity were further researched
    设计合成了四个系列的螺[苯并恶嗪-哌啶]-酮衍生物。评估了它们对几丁质合酶和抗真菌活性的抑制百分比。在初步生物测定的基础上,进一步研究了一系列具有中至优异CHS抑制活性和抗真菌活性的α,β-不饱和羰基片段衍生物。在这一系列化合物中,21种化合物中有8种对几丁质合酶具有良好至优异的抑制活性,在300 μg/mL浓度下抑制百分率值在60%以上。其中化合物9a、9o、9s和9t表现出优异的几丁质合酶抑制活性,IC 50值分别为 0.14 mM、0.11 mM、0.10 mM 和 0.16 mM,这与对照药物 (polyoxin B) 的值相同。山梨醇保护试验的结果和对米卡芬净抗性真菌的抗真菌活性评估进一步证明了这些合成化合物的靶点是几丁质合酶。抗真菌活性评价表明,化合物9a、9d、9h、9s、9t在体外具有广谱抗真菌活性,其抗真菌活性与氟康唑和多恶英B相当。联合使用结果表明该系列化合物与氟康唑具
  • Graphene Oxide as a Carbocatalyst for a Diels-Alder Reaction in an Aqueous Medium
    作者:Yarabhally R. Girish、Subrata Pandit、Subhendu Pandit、Mrinmoy De
    DOI:10.1002/asia.201701072
    日期:2017.9.19
    six‐membered rings. Herein, we report an efficient protocol for the DA reaction between 9‐hydroxymethylanthracene and N‐substituted maleimides using two‐dimensional graphene oxide (GO) as a heterogeneous carbocatalyst in an aqueous medium at room temperature. High yields, a wide substrate scope, low temperature, excellent functional group tolerance, atom economy, and water as a green solvent are noteworthy
    Diels–Alder(DA)反应是[4 + 2]环加成反应,在合成有机化学中非常重要,经常用于合成包含六元环的天然产物。在本文中,我们报告了在室温下使用二维氧化石墨烯(GO)作为非均相碳催化剂在9-羟甲基蒽和N-取代的马来酰亚胺之间进行DA反应的有效方案。高收率,广泛的底物范围,低温,出色的官能团耐受性,原子经济性以及水作为绿色溶剂是该协议的重要功能。该多相GO催化剂可以容易地回收并多次使用,而催化活性没有任何明显的损失。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐